These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7121610)

  • 1. Nitroimipramines - synthesis and pharmacological effects of potent long-acting inhibitors of [3H] serotonin uptake and [3H] imipramine binding.
    Rehavi M; Ittah Y; Skolnick P; Rice KC; Paul SM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Jul; 320(1):45-9. PubMed ID: 7121610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic properties of [3H]2-nitroimipramine binding to human platelets.
    Davis A
    Eur J Pharmacol; 1983 Dec; 96(1-2):105-10. PubMed ID: 6662191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 5. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Nitroimipramine: a photoaffinity probe for the serotonin uptake/tricyclic binding site complex.
    Wennogle LP; Ashton RA; Schuster DI; Murphy RB; Meyerson LR
    EMBO J; 1985 Apr; 4(4):971-7. PubMed ID: 4018038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinase inhibitors compete with imipramine for binding and inhibition of serotonin transport.
    Helmeste DM; Tang SW
    Eur J Pharmacol; 1994 Apr; 267(2):239-42. PubMed ID: 8050484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet uptake of serotonin following repeated administration of 3-cyano-imipramine to healthy volunteers.
    Lenehan TJ; Kenny M; Omer LM; Lambe R; Brick I; Darragh A
    Psychopharmacology (Berl); 1983; 81(4):357-8. PubMed ID: 6419264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.
    Wennogle LP; Meyerson LR
    Life Sci; 1985 Apr; 36(16):1541-50. PubMed ID: 3982224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorimipramine--but not imipramine--rapidly reduces [3H]imipramine binding in human platelet membranes.
    Mellerup ET; Plenge P
    Eur J Pharmacol; 1986 Jul; 126(1-2):155-8. PubMed ID: 3758160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]imipramine binding of protein nature in human platelets: inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitors.
    Marcusson J; Tiger G
    J Neurochem; 1988 Apr; 50(4):1032-6. PubMed ID: 3279163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclasses of platelet 3H-imipramine binding sites.
    DeMet EM; Chicz-DeMet A
    Psychiatry Res; 1990 Dec; 34(3):293-302. PubMed ID: 1963692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers.
    Sette M; Briley MS; Langer SZ
    J Neurochem; 1983 Mar; 40(3):622-8. PubMed ID: 6827265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3H-imipramine binding and serotonin uptake in platelets from untreated depressed patients and control volunteers.
    Raisman R; Briley MS; Bouchami F; Sechter D; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1982; 77(4):332-5. PubMed ID: 6813892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.